24/7 Market News - Kraig Biocraft Advances Toward First-Ever Spider Silk Deliveries to Luxury and Performance Giants
Denver, Colorado--(Newsfile Corp. - June 3, 2025) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, features the key highlights from a compelling shareholder letter by Kim Thompson, the CEO of Kraig Biocraft Laboratories (OTCQB: KBLB), the undisputed global leader in the development and commercialization of spider silk. The letter detailed groundbreaking scientific advancements, robust production progress, and a commercial pivot toward high-profile global partnerships, including these key takeaways:
[ This image cannot be displayed. Please visit the source: https://images.newsfilecorp.com/files/10481/254318_kraiglogo.jpg ]
Kraig Biocraft Laboratories Logo
Global Brands Standing by for First Spider Silk Shipments
Kraig Labs entered active commercial discussions with three major global brands that are preparing to receive initial spider silk shipments.
'We are in regular communication with three major global brands that are standing by to receive their first shipments of materials,' the letter stated.
These include:
'Currently, we expect to begin deliveries to these customers in the second half of this year.'
New Double Hybrid Strain on Track for 2025 Launch
A major scientific milestone was confirmed with the announcement that the Company's next-generation production model—the double hybrid system—remains fully on track for deployment in 2025, which is critical to launching its double hybrid system, marking a significant leap in scalability and efficiency.
'Our longstanding plans were to field a new strain of silkworm for our double hybrid production system in the Summer of 2025... We were, therefore, ecstatic to announce that we created another world's first development on schedule.'
This breakthrough is expected to boost production output by 25% or more monthly.
'The double hybrid model is designed to significantly improve our silk production rate, we expect by as much as 25+% per month.'
[ This image cannot be displayed. Please visit the source: https://images.newsfilecorp.com/files/10481/254318_kraig1.jpg ]
Kraig Lab BAM-1 Recombinant Spider Silk Cocoons
BAM-1 Hybrid Demonstrates Industry-Leading Resilience
Kraig Biocraft's current BAM-1 hybrid system has already delivered major gains in disease resistance and reliability, matching the robustness and disease tolerance of the Chinese commercial silk hybrid, the regional gold standard.
'The BAM-1 appears to be on par with the Chinese commercial silk hybrid, which is the gold standard in that region for the production of mundane silk.'
This leap in robustness has mitigated previous challenges with silkworm diseases and environmental stress. This resilience ensures more reliable production cycles, even in difficult environmental conditions like the current rainy season affecting global silk producers.
'Since rolling out the BAM-1, we have dealt with these routine challenges and have weathered these events with similar or identical effects as mundane silk producers utilizing the Chinese hybrid.'
Work-in-Progress Inventory to Reflect True Output
The Company confirmed that several hundred kilograms of recombinant spider silk cocoon are now awaiting to be processed into finished silk. Kraig will begin including this in its work-in-progress (WIP) inventory accounting, to better reflect the company's shift to larger-scale production.
'We will expand the scope of our work-in-progress (WIP) material inventory to include recombinant spider silk cocoon that has been completed but not reeled.'
This shift comes as hundreds of kilograms of spider silk cocoons await processing, laying the groundwork for larger-scale deliveries.
'In the first quarter of this year, we stockpiled several hundred kilograms of cocoon that are now waiting to be processed into finished silk.'
This inventory expansion marks a transition from nominal production to commercial-scale operations.
Spider Silk Technology at a Tipping Point
The past year has seen what the Company describes as a 'revolution' in its spider silk production technology.
'In short, there has been a revolution in our spider silk production technology over the past 14 months due to the introduction of BAM-1 and other improvements in the field and laboratory.'
Robust strain development, improved disease tolerance, and steady production have laid the groundwork for scalable, high-yield manufacturing.
'As we meet our marks toward the initiation of the double hybrid, we anticipate our gains to accelerate further.'
Commercial Focus and Execution at the Forefront
The letter also emphasized that spider silk production remains Kraig's exclusive and that execution is rapidly accelerating.
'In the last 8-10 months, we've been able to move faster to deliver on that commitment.'
Revolution in Spider Silk Production: Over the past 14 months, Kraig Labs has achieved a 'revolution' in its spider silk technology, overcoming historical robustness issues and positioning the company for accelerated growth as it prepares for the double hybrid system rollout.
The combination of scientific breakthroughs, increased output, and major brand engagement positions Kraig Biocraft for commercial revenue generation.
Focused Execution and Commercial Outlook
CEO Kim Thompson concluded the letter with a reaffirmation of Kraig Labs' unwavering mission:
'We are 100% focused on the production of spider silk for commercial delivery. Over the last year, we've been able to move faster to deliver on that commitment.'
'I believe the future for Kraig Labs and spider silk has never been brighter, and we thank you for your continued support.'
Kraig emphasized that 100% of its focus is on spider silk production, and that accelerated progress over the past 8-10 months has positioned the company for its most important year yet. With foundational technology in place, the path to scaled commercialization and revenue generation is clearer than ever.
With next-gen technology on schedule, scaled inventory building underway, and three industry giants preparing to receive initial shipments, Kraig Biocraft Laboratories is transitioning from a research-centric biotech into a commercially viable materials science innovator.
Please click here for the full letter.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) is a biotechnology company focused on the development and commercialization of spider silk-based fiber technologies. Through its proprietary silkworm-based genetic engineering platform, Kraig Labs produces high-performance, cost-effective, and scalable spider silk materials for use in defense, performance apparel, technical textiles, and medical applications.
For more information, please visit: www.kraiglabs.com
Please click here to read the full Kraig Labs analyst report on 247marketnews.com.
Contact [email protected] for Analyst Report coverage and other investor/public relations services.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/kblb-disclosure/ for disclaimer information.
About 24/7 Market News
24/7 Market News is a leading platform for public company market news. As a pioneer in digital media, we are committed to the rapid dissemination of financial market news and information. We excel in creating innovative public relations campaigns to help our clients effectively reach their target audience. 24/7 Market News offers paid coverage for public companies. For more information or PR inquiries, please contact: [email protected]
Please go to www.247marketnews.com for further information.
CONTACT:
24/7 Market News
[email protected]
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words 'intends,' 'may,' 'will,' 'plans,' 'expects,' 'anticipates,' 'projects,' 'predicts,' 'estimates,' 'aims,' 'believes,' 'hopes,' 'potential' or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company's ability to continue as a going concern, the popularity and/or competitive success of the Company's acquired football and other sports teams, the Company's ability to attract players and staff for acquired clubs, unsuccessful acquisitions or other strategic transactions, the possibility of a decline in the popularity of football or other sports, the Company's ability to expand its fanbase, sponsors and commercial partners, general economic conditions, and other risk factors detailed in the Company's filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/254318
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
UPI
9 minutes ago
- UPI
China imposes exit bans on Wells Fargo banker, U.S. government worker
The Chinese government is preventing a Wells Fargo employee, as well as an employee of the U.S. Patent and Trademark Office, from leaving the country. File Photo by Larry W. Smith/EPA-EFE July 20 (UPI) -- The Chinese government is preventing a Chinese American banker for Wells Fargo and, separately, an employee of the U.S. Patent and Trademark Office from leaving the country, reports said Sunday. The identity of the detained U.S. government employee was not known to the Washington Post, which first reported the news. Mao Chenyue, the managing director of Wells Fargo Credit Solutions, was confirmed as the bank employee facing the exit ban by the company in statements to The New York Times and the Wall Street Journal. People familiar with the Patent and Trademark Office employee's case told the Washington Post that he traveled to China to visit family but allegedly failed to disclose on his visa application that he worked for the government. Wells Fargo has since reportedly suspended travel by its executives to China, noting in its statement to The New York Times that the company is tracking the situation and working "through the appropriate channels" to ensure their employee is returned. The company did not provide any details as to why Mao was prevented from leaving the country but noted that she has not been detained in China and is free to move about the country. "We have raised our concern with Chinese authorities about the impact arbitrary exit bans on U.S. citizens have on our bilateral relations and urged them to immediately allow impacted U.S. citizens to return home," said a U.S. Embassy in Beijing spokesperson. A Chinese Foreign Ministry spokesman was asked about Mao's exit ban on Friday but said he was not aware of it. Her LinkedIn account, reviewed by UPI, shows that she was active on social media as recently as two weeks ago when she thanked people for congratulatory messages on her recent election as chairman of FCI.
Boston Globe
38 minutes ago
- Boston Globe
As Trump courts a more assertive Beijing, China hawks are losing out
The move was a dramatic reversal from three months ago, when President Trump banned China from accessing the H20, while also imposing triple-digit tariffs on Beijing. That set off an economically perilous trade clash, as China retaliated by clamping down on exports of minerals and magnets that are critical to American factories, including automakers and defense manufacturers. China's decision to cut off access to those materials upended the dynamic between the world's largest economies. The Trump administration, which came into office determined to bully China into changing its trade behavior with punishing tariffs, appeared to realize the perils of that approach. Now, the administration has resorted to trying to woo China instead. Officials throughout the government say the Trump administration is putting more aggressive actions against China on hold, while pushing forward with moves that the Chinese will perceive positively. That includes the reversal on the H20 chip. Advertisement The H20 decision was primarily motivated by top Trump officials who agreed with Nvidia's arguments that selling the chip would be better for American technology leadership than withholding it, people familiar with the move say. But Trump officials have also claimed that it was part of the trade talks. After telling Congress in June that there was 'no quid pro quo in terms of chips for rare earths,' Scott Bessent, the treasury secretary, reversed those comments Tuesday, saying that the H20 move was 'all part of a mosaic' of talks with China. 'They had things we wanted, we had things they wanted, and we're in a very good place,' he said. Advertisement A Chinese Ministry of Commerce official seemed to reject that Friday, saying that the United States had 'taken the initiative' to approve the H20 sales. China believes the United States should continue to remove its trade and economic restrictions, the official said. A person familiar with the talks, who spoke on the condition of anonymity because he was not authorized to speak publicly, said that the H20 chip was not specifically discussed in meetings between Chinese and US officials in Geneva and London this spring. But the reversal was part of a more recent cadence of warmer actions the United States and China have taken toward each other. For instance, Beijing agreed in recent weeks to block the export of several chemicals used to make fentanyl, an issue Trump has been concerned about. Recent events have underscored the influence that China has over the US economy. When Trump raised tariffs on Chinese exports in April, some top Trump officials thought Beijing would quickly fold, given its recent economic weakness. Instead, Beijing called Trump's bluff by restricting rare earths needed by American makers of cars, military equipment, medical devices, and electronics. As the flow of those materials stopped, Trump and other officials began receiving calls from CEOs saying their factories would soon shut down. Ford, Suzuki, and other companies shuttered factories because of the lack of supply. Advertisement Trump and his top advisers were surprised by the threat that Beijing's countermove posed, people familiar with the matter say. That brought the United States back to the negotiating table this spring to strike a fragile trade truce, which Trump officials are now wary of upsetting. That agreement dropped tariffs from a minimum 145 percent to 30 percent, with the Chinese agreeing to allow rare earths to flow as freely as before. The administration's caution when it comes to China has been amplified by Trump's desire for an invitation to Beijing later this year. The president, who has been feted on other foreign trips, wants to engage in face-to-face trade negotiations with Chinese leader Xi Jinping. Howard Lutnick, the commerce secretary, has begun recruiting chief executives for a potential delegation, setting off a competition over who will get to ride in Air Force One, according to people familiar with the plans. The Commerce Department declined to comment. The White House, the Treasury Department, and the Office of the United States Trade Representative did not respond to a request for comment. 'The government understands that forcing the world to use foreign competition would only hurt America's economic and national security,' said John Rizzo, a spokesperson for Nvidia. Opposition to China has fueled bipartisan action for the past decade. Now, Trump's more hawkish supporters are quietly watching as the president remakes the party's China strategy. Though few are willing to speak out publicly, officials in the Trump administration and in Congress have privately expressed concern that the trade war has given China an opening to finally bring US technology controls onto the negotiating table. Advertisement Christopher Padilla, a former export control official in the George W. Bush administration, said the fact that the United States was now negotiating over what were supposed to be security restrictions was 'a significant accomplishment for the Chinese.' 'They've been after this for decades, and now they've succeeded,' he said. 'I assume the Chinese are going to demand more concessions on export controls in return for whatever we want next.' This article originally appeared in
Business Upturn
2 hours ago
- Business Upturn
CLF Investor News: If You Have Suffered Losses in Cleveland-Cliffs Inc. (NYSE: CLF), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, July 20, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Cleveland-Cliffs Inc. (NYSE: CLF) resulting from allegations that Cliffs may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Cliffs securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. WHAT TO DO NEXT: To join the prospective class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. WHAT IS THIS ABOUT: On May 7, 2025, Cliffs issued a press release containing its financial results for the first quarter of 2025. In part, Cliffs reported a $483 million GAAP net loss for the quarter, compared to a $434 million GAAP net loss for the fourth quarter of 2024. Further, Cliffs announced that it had 'made the decision to fully or partially idle six facilities to optimize its footprint, reposition away from loss-making operations, and release excess working capital.' The press release contained a statement from Cliffs' CEO, who stated in part that Cliffs' 'first-quarter results were negatively impacted by underperforming non-core assets and the lagging effect of lower index prices in late 2024 and early 2025.' On this news, Cliffs' stock fell over 15% on May 8, 2025, and a further 2% on May 9, 2025. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. ——————————- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected]
